Table of Content

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What’s New in this Update
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown

Chapter 2 Summary and Highlights
Market Overview
Market Summary

Chapter 3 Market and Technology Background
Introduction
History and Current State
Background of the Antibody and Its Production
Current Status and Issues
Overview of Antibody Technology
Traditional Antibody Generation Technologies
Antibody Generation Technologies
Antibody Validation Methods
Trends in the Market for Research Antibodies
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Research Grants
Journal Citations Analysis
Technological Trends in Antibody Production and Application

Chapter 4 Research Antibodies
Introduction
Enzyme-Linked Immunosorbent Assay/Enzyme-Linked Immunosorbent Spot
Direct ELISA
Indirect ELISA
Competitive ELISA
Sandwich ELISA
ELISPOT Assays
FluoroSpot Assays
Emerging Technologies or Platforms in ELISA
Western Blot
One-Dimensional Gel Electrophoresis
Two-Dimensional Gel Electrophoresis
Emerging Technologies and Platforms in Western Blot
Immunohistochemistry
Multiplexed Staining
Low-Flexed Staining
Flow Cytometry
Emerging Technologies/Platforms in Flow Cytometry
Immunocytochemistry and Immunofluorescent Staining
Chromatin Immunoprecipitation
Other Antibody Applications
Antibody Arrays

Chapter 5 Market Dynamics
Market Drivers
New Discoveries in Biological Sciences
Rapid Technological Developments in the In Vitro Diagnostic Industry
New Antibody Technologies and Types
Antibody-Based Drug Discovery and Development
Developed and Increasing Research Areas
Increased Government Funding in Emerging Markets
Need for Further Human Genomic and Proteomic Research
Need for Quality Antibodies in the Current Research Community
Need for Antibody Custom Services
New Application-Focused Technology Platforms
Market Restraints
Limited Research Funding
Low Validation Technologies
Decline in Suppliers
Decrease in Market Acceptance or Brand Trust
Market and Economic Risk
Market Opportunities
Market Expansion into Emerging Countries
Development of Novel Research Antibodies

Chapter 6 Market Breakdown by Type of Antibody
Global Market for Research Antibodies by Type
Primary Antibodies
Secondary Antibodies

Chapter 7 Market Breakdown by Clonality
Global Market for Research Antibodies by Clonality
Polyclonal Antibodies
Monoclonal Antibodies
Recombinant Antibodies

Chapter 8 Market Breakdown by Major Reactivity
Global Market for Research Antibodies by Major Reactivity
Human (Anti-Human)
Mouse (Anti-Mouse)
Rat (Anti-Rat)
Others

Chapter 9 Market Breakdown by Application
Global Market for Research Antibodies by Application
Western Blot
Flow Cytometry
Immunohistochemistry
Immunocytochemistry
Immunofluorescent Staining
Immunoprecipitation
ELISA

Chapter 10 Market Breakdown by Host Species
Global Market for Research Antibodies by Host Species
Rabbit Host Species
Goat Host Species
Mouse-Host Species
Sheep Host Species
Donkey Host Species
Other Host Species

Chapter 11 Market Breakdown by End User
Global Market for Research Antibodies by End User
Universities and Academic Institutions
Pharma and Biotech Companies
Other End Users

Chapter 12 Market Breakdown by Region
Global Market for Research Antibodies by Region
North America
Europe
Asia-Pacific
Rest of World

Chapter 13 Sustainability in the Research Antibodies Industry: An Environment, Social and Governance Sustainability in the Research
Importance of Environment, Social and Governance in the Research Antibodies Manufacturing Industry
Environment, Social and Governance Ratings and Metrics: Understanding the Data
Environmental, Social and Governance Practices in the Research Antibodies Manufacturing Industry
Environmental Performance
Social Performance
Governance Performance
Case Studies

Chapter 14 Emerging Technology for Antibody Discovery and Generation
Traditional Antibody Discovery and Generation Technologies
Animal Plasma Isolation
Hybridoma Generation
B Cell Screening
Display Technologies
Emerging Antibody Discovery and Generation Technologies
Emerging Trends in the Antibody Production Technologies
Polyclonal Antibody Sequencing
Single B Cell Sequencing
Machine Learning-Assisted Discovery and Generation
Advantages and Disadvantages of Antibody Discovery Technol0gies
Examples of Antibody Production and Technologies
REpAb Technology
Boehringer Ingelheim’s Partnership with Company
COVID-19 Vaccines by EABR Technology
First Therapeutic Antibody
Challenges and Future Research Direction

Chapter 15 Approved Monoclonal Antibodies, 2018-2023

Chapter 16 M&A and Venture Funding Outlook
Mergers and Acquisitions Analysis
Merger and Acquisition Deals: 2018–2023

Chapter 17 Competitive Landscape
Global Company Market Ranking
Distribution of the WHO’s International Standard for Anti-SARS-CoV-2 Immunoglobulin
Top 100 Antibodies by Major Key Companies

Chapter 18 Company Profiles
ABCAM PLC
ABSOLUTE ANTIBODY LTD.
AGILENT TECHNOLOGIES INC.
BD BIOSCIENCES
BIO-RAD (ABD SEROTEC)
BIO-TECHNE
CELL SIGNALING TECHNOLOGY INC.
DANAHER
JACKSON IMMUNORESEARCH LABORATORIES INC.
LONZA
MERCK KGAA (SIGMA-MILLIPORE)
ROCKLAND IMMUNOCHEMICALS INC.
SANTA CRUZ BIOTECHNOLOGY INC.
SINO BIOLOGICAL INC.
THERMO FISHER SCIENTIFIC INC.
UNITED STATES BIOLOGICAL

Chapter 19 Appendix: Acronyms



List of Figures

 

Summary Figure : Global Market Shares of Research Antibodies, by Application, 2022
Figure :
Figure 1 : Global Markets for Research Antibodies Market Dynamics
Figure 2 : Global Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 3 : Global Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 4 : Global Market for Primary Antibodies, 2020–2028
Figure 5 : Global Market for Primary Antibodies, by Region, 2020–2028
Figure 6 : Global Market for Secondary Antibodies, 2020–2028
Figure 7 : Global Market for Secondary Antibodies, by Region, 2020–2028
Figure 8 : Global Market Shares of Research Antibodies, by Clonality, 2022
Figure 9 : Global Market Shares of Research Antibodies, by Clonality, 2028
Figure 10 : Global Market for Polyclonal Antibodies, 2020–2028
Figure 11 : Global Market for Polyclonal Antibodies, by Region, 2020–2028
Figure 12 : Global Market for Monoclonal Antibodies, 2020–2028
Figure 13 : Global Market for Monoclonal Antibodies, by Region, 2020–2028
Figure 14 : Global Market for Recombinant Antibodies, 2020–2028
Figure 15 : Global Market for Recombinant Antibodies, by Region, 2020–2028
Figure 16 : Global Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 17 : Global Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 18 : Global Market for Anti-Human Antibodies, 2020–2028
Figure 19 : Global Market for Anti-Human Antibodies, by Region, 2020–2028
Figure 20 : Global Market for Anti-Mouse Antibodies, 2020–2028
Figure 21 : Global Market for Anti-Mouse Antibodies, by Region, 2020–2028
Figure 22 : Global Market for Anti-Rat Antibodies, 2020–2028
Figure 23 : Global Market for Anti-Rat Antibodies, by Region, 2020–2028
Figure 24 : Global Market for Other Research Antibodies, 2020–2028
Figure 25 : Global Market for Other Research Antibodies, by Region, 2020–2028
Figure 26 : Global Market Shares of Research Antibodies, by Application, 2022
Figure 27 : Global Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 28 : Global Market Shares of Research Antibodies, by Application, 2028
Figure 29 : Global Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 30 : Global Market for Western Blot Applications, 2020–2028
Figure 31 : Global Market for Western Blot Applications, by Region, 2020–2028
Figure 32 : Global Market for Flow Cytometry Applications, 2020–2028
Figure 33 : Global Market for Flow Cytometry Applications, by Region, 2020–2028
Figure 34 : Estimated New Cases of Leukemia, Lymphoma and Myeloma, 2020
Figure 35 : Global Market for Immunohistochemistry Applications, 2020–2028
Figure 36 : Global Market for Immunohistochemistry Applications, by Region, 2020–2028
Figure 37 : Global Market for Multiplex Staining Applications, 2020–2028
Figure 38 : Global Market for Multiplex Staining Applications, by Region, 2020–2028
Figure 39 : Global Market for Low-Flexed Staining Applications, 2020–2028
Figure 40 : Global Market for Low-Flexed Staining Applications, by Region, 2020–2028
Figure 41 : Global Market for Immunocytochemistry Applications, 2020–2028
Figure 42 : Global Market for Immunocytochemistry Applications, by Region, 2020–2028
Figure 43 : Global Market for Immunofluorescent Applications, 2020–2028
Figure 44 : Global Market for Immunofluorescent Applications, by Region, 2020–2028
Figure 45 : Global Market for Immunoprecipitation Applications, 2020–2028
Figure 46 : Global Market for Immunoprecipitation Applications, by Region, 2020–2028
Figure 47 : Global Market for ELISA Applications, 2020–2028
Figure 48 : Global Market for ELISA Applications, by Region, 2020–2028
Figure 49 : Global Market Shares of Research Antibodies, by Host Species, 2022
Figure 50 : Global Market Shares of Research Antibodies, by Host Species, 2028
Figure 51 : Rabbits Used in Research, Testing and Teaching in the U.S., 2012–2021
Figure 52 : Global Market for Rabbit Research Antibodies, 2020–2028
Figure 53 : Global Market for Rabbit Research Antibodies, by Region, 2020–2028
Figure 54 : Global Market for Goat Research Antibodies, 2020–2028
Figure 55 : Global Market for Goat Research Antibodies, by Region, 2020–2028
Figure 56 : Global Market for Mouse Research Antibodies, 2020–2028
Figure 57 : Global Market for Mouse Research Antibodies, by Region, 2020–2028
Figure 58 : Antigen-Antibody Interaction Between Mouse mAb and Four Human Enterovirus
Figure 59 : Global Market for Sheep Research Antibodies, 2020–2028
Figure 60 : Global Market for Sheep Research Antibodies, by Region, 2020–2028
Figure 61 : Global Market for Donkey Research Antibodies, 2020–2028
Figure 62 : Global Market for Donkey Research Antibodies, by Region, 2020–2028
Figure 63 : Global Market for Other Research Antibodies, 2020–2028
Figure 64 : Global Market for Other Research Antibodies, by Region, 2020–2028
Figure 65 : Global Market Shares of Research Antibodies, by End User, 2022
Figure 66 : Global Market Shares of Research Antibodies, by End User, 2028
Figure 67 : Global Incidence of Patients with Chronic Diseases, 2005–2030
Figure 68 : Global Market for Research Antibodies Used by Universities and Academic Institutions, 2020–2028
Figure 69 : Global Market for Research Antibodies Used by Universities and Academic Institutions, by Region, 2020–2028
Figure 70 : Global Market for Research Antibodies Used by Pharma and Biotech Companies, 2020–2028
Figure 71 : Global Market for Research Antibodies Used by Pharma and Biotech Companies, by Region, 2020–2028
Figure 72 : Global Market for Research Antibodies Used by Other End Users, 2020–2028
Figure 73 : Global Market for Research Antibodies Used by Other End Users, by Region, 2020–2028
Figure 74 : Global Market Shares of Research Antibodies, by Region, 2022
Figure 75 : Global Market Shares of Research Antibodies, by Region, 2028
Figure 76 : People Aged 65 Years or Older with Alzheimer’s Dementia in the U.S., 2023
Figure 77 : Alzheimer’s Disease Facts, 2023
Figure 78 : North American Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 79 : North American Market Shares of Research Antibodies, by Clonality, 2022
Figure 80 : North American Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 81 : North American Market Shares of Research Antibodies, by Application, 2022
Figure 82 : North American Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 83 : North American Market Shares of Research Antibodies, by Host Species, 2022
Figure 84 : North American Market Shares of Research Antibodies, by End User, 2022
Figure 85 : North American Market Shares of Research Antibodies, by Country, 2022
Figure 86 : U.S. Market for Research Antibodies, 2020–2028
Figure 87 : U.S. Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 88 : U.S. Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 89 : U.S. Market Shares of Research Antibodies, by Clonality, 2022
Figure 90 : U.S. Market Shares of Research Antibodies, by Clonality, 2028
Figure 91 : U.S. Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 92 : U.S. Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 93 : U.S. Market Shares of Research Antibodies, by Application, 2022
Figure 94 : U.S. Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 95 : U.S. Market Shares of Research Antibodies, by Application, 2028
Figure 96 : U.S. Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 97 : U.S. Market Shares of Research Antibodies, by Host Species, 2022
Figure 98 : U.S. Market Shares of Research Antibodies, by Host Species, 2028
Figure 99 : U.S. Market Shares of Research Antibodies, by End User, 2022
Figure 100 : U.S. Market Shares of Research Antibodies, by End User, 2028
Figure 101 : Canadian Market for Research Antibodies, 2020–2028
Figure 102 : Canadian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 103 : Canadian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 104 : Canadian Market Shares of Research Antibodies, by Clonality, 2022
Figure 105 : Canadian Market Shares of Research Antibodies, by Clonality, 2028
Figure 106 : Canadian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 107 : Canadian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 108 : Canadian Market Shares of Research Antibodies, by Application, 2022
Figure 109 : Canadian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 110 : Canadian Market Shares of Research Antibodies, by Application, 2028
Figure 111 : Canadian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 112 : Canadian Market Shares of Research Antibodies, by Host Species, 2022
Figure 113 : Canadian Market Shares of Research Antibodies, by Host Species, 2028
Figure 114 : Canadian Market Shares of Research Antibodies, by End User, 2022
Figure 115 : Canadian Market Shares of Research Antibodies, by End User, 2028
Figure 116 : Mexican Market for Research Antibodies, 2020–2028
Figure 117 : Mexican Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 118 : Mexican Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 119 : Mexican Market Shares of Research Antibodies, by Clonality, 2022
Figure 120 : Mexican Market Shares of Research Antibodies, by Clonality, 2028
Figure 121 : Mexican Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 122 : Mexican Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 123 : Mexican Market Shares of Research Antibodies, by Application, 2022
Figure 124 : Mexican Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 125 : Mexican Market Shares of Research Antibodies, by Application, 2028
Figure 126 : Mexican Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 127 : Mexican Market Shares of Research Antibodies, by Host Species, 2022
Figure 128 : Mexican Market Shares of Research Antibodies, by Host Species, 2028
Figure 129 : Mexican Market Shares of Research Antibodies, by End User, 2022
Figure 130 : Mexican Market Shares of Research Antibodies, by End User, 2028
Figure 131 : European Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 132 : European Market Shares of Research Antibodies, by Clonality, 2022
Figure 133 : European Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 134 : European Market Shares of Research Antibodies, by Application, 2022
Figure 135 : European Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 136 : European Market Shares of Research Antibodies, by Host Species, 2022
Figure 137 : European Market Shares of Research Antibodies, by End User, 2022
Figure 138 : European Market Shares of Research Antibodies, by Country, 2022
Figure 139 : German Market for Research Antibodies, 2020–2028
Figure 140 : German Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 141 : German Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 142 : German Market Shares of Research Antibodies, by Clonality, 2022
Figure 143 : German Market Shares of Research Antibodies, by Clonality, 2028
Figure 144 : German Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 145 : German Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 146 : German Market Shares of Research Antibodies, by Application, 2022
Figure 147 : German Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 148 : German Market Shares of Research Antibodies, by Application, 2028
Figure 149 : German Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 150 : German Market Shares of Research Antibodies, by Host Species, 2022
Figure 151 : German Market Shares of Research Antibodies, by Host Species, 2028
Figure 152 : German Market Shares of Research Antibodies, by End User, 2022
Figure 153 : German Market Shares of Research Antibodies, by End User, 2028
Figure 154 : German Global Health Spending, by Subsector, 2021
Figure 155 : German Global Health Spending, 2021
Figure 156 : French Market for Research Antibodies, 2020–2028
Figure 157 : French Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 158 : French Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 159 : French Market Shares of Research Antibodies, by Clonality, 2022
Figure 160 : French Market Shares of Research Antibodies, by Clonality, 2028
Figure 161 : French Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 162 : French Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 163 : French Market Shares of Research Antibodies, by Application, 2022
Figure 164 : French Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 165 : French Market Shares of Research Antibodies, by Application, 2028
Figure 166 : French Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 167 : French Market Shares of Research Antibodies, by Host Species, 2022
Figure 168 : French Market Shares of Research Antibodies, by Host Species, 2028
Figure 169 : French Market Shares for Research Antibodies, by End User, 2022
Figure 170 : French Market Shares of Research Antibodies, by End User, 2028
Figure 171 : France Expected Diagnosed Cancer for Women, 2020
Figure 172 : France Expected Diagnosed Cancer for Men, 2020
Figure 173 : French Health Spending and Financing, 2015–2020
Figure 174 : U.K. Market for Research Antibodies, 2020–2028
Figure 175 : U.K. Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 176 : U.K. Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 177 : U.K. Market Shares of Research Antibodies, by Clonality, 2022
Figure 178 : U.K. Market Shares of Research Antibodies, by Clonality, 2028
Figure 179 : U.K. Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 180 : U.K. Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 181 : U.K. Market Shares of Research Antibodies, by Application, 2022
Figure 182 : U.K. Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 183 : U.K. Market Shares of Research Antibodies, by Application, 2028
Figure 184 : U.K. Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 185 : U.K. Market Shares of Research Antibodies, by Host Species, 2022
Figure 186 : U.K. Market Shares of Research Antibodies, by Host Species, 2028
Figure 187 : U.K. Market Shares of Research Antibodies, by End User, 2022
Figure 188 : U.K. Market Shares of Research Antibodies, by End User, 2028
Figure 189 : Italian Market for Research Antibodies, 2020–2028
Figure 190 : Italian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 191 : Italian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 192 : Italian Market Shares of Research Antibodies, by Clonality, 2022
Figure 193 : Italian Market Shares of Research Antibodies, by Clonality, 2028
Figure 194 : Italian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 195 : Italian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 196 : Italian Market Shares of Research Antibodies, by Application, 2022
Figure 197 : Italian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 198 : Italian Market Shares of Research Antibodies, by Application, 2028
Figure 199 : Italian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 200 : Italian Market Shares of Research Antibodies, by Host Species, 2022
Figure 201 : Italian Market Shares of Research Antibodies, by Host Species, 2028
Figure 202 : Italian Market Shares of Research Antibodies, by End User, 2022
Figure 203 : Italian Market Shares of Research Antibodies, by End User, 2028
Figure 204 : Leading Subsectors in Italy, 2020
Figure 205 : Spanish Market for Research Antibodies, 2020–2028
Figure 206 : Spanish Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 207 : Spanish Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 208 : Spanish Market Shares of Research Antibodies, by Clonality, 2022
Figure 209 : Spanish Market Shares of Research Antibodies, by Clonality, 2028
Figure 210 : Spanish Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 211 : Spanish Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 212 : Spanish Market Shares of Research Antibodies, by Application, 2022
Figure 213 : Spanish Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 214 : Spanish Market Shares of Research Antibodies, by Application, 2028
Figure 215 : Spanish Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 216 : Spanish Market Shares of Research Antibodies, by Host Species, 2022
Figure 217 : Spanish Market Shares of Research Antibodies, by Host Species, 2028
Figure 218 : Spanish Market Shares of Research Antibodies, by End User, 2022
Figure 219 : Spanish Market Shares of Research Antibodies, by End User, 2028
Figure 220 : Rest of European Market for Research Antibodies, 2020–2028
Figure 221 : Rest of European Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 222 : Rest of European Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 223 : Rest of European Market Shares of Research Antibodies, by Clonality, 2022
Figure 224 : Rest of European Market Shares of Research Antibodies, by Clonality, 2028
Figure 225 : Rest of European Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 226 : Rest of European Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 227 : Rest of European Market Shares of Research Antibodies, by Application, 2022
Figure 228 : Rest of European Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 229 : Rest of European Market Shares of Research Antibodies, by Application, 2028
Figure 230 : Rest of European Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 231 : Rest of European Market Shares of Research Antibodies, by Host Species, 2022
Figure 232 : Rest of European Market Shares of Research Antibodies, by Host Species, 2028
Figure 233 : Rest of European Market Shares of Research Antibodies, by End User, 2022
Figure 234 : Rest of European Market Shares of Research Antibodies, by End User, 2028
Figure 235 : Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 236 : Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2022
Figure 237 : Asia-Pacific Market Shares of Research Antibodies Market, by Major Reactivity, 2022
Figure 238 : Asia-Pacific Market Shares of Research Antibodies, by Application, 2022
Figure 239 : Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 240 : Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2022
Figure 241 : Asia-Pacific Market Shares of Research Antibodies, by End User, 2022
Figure 242 : Regional Growth in Multi-specific Monoclonal Antibodies, by Region, 2018–2022
Figure 243 : Asia-Pacific Market Shares of Research Antibodies, by Country, 2022
Figure 244 : Japanese Market for Research Antibodies, 2020–2028
Figure 245 : Japanese Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 246 : Japanese Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 247 : Japanese Market Shares of Research Antibodies, by Clonality, 2022
Figure 248 : Japanese Market Shares of Research Antibodies, by Clonality, 2028
Figure 249 : Japanese Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 250 : Japanese Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 251 : Japanese Market Shares of Research Antibodies, by Application, 2022
Figure 252 : Japanese Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 253 : Japanese Market Shares of Research Antibodies, by Application, 2028
Figure 254 : Japanese Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 255 : Japanese Market Shares of Research Antibodies, by Host Species, 2022
Figure 256 : Japanese Market Shares of Research Antibodies, by Host Species, 2028
Figure 257 : Japanese Market Shares of Research Antibodies, by End User, 2022
Figure 258 : Japanese Market Shares of Research Antibodies, by End User, 2028
Figure 259 : Top Five Antibody Suppliers Shares in Japan, 2021
Figure 260 : Chinese Market for Research Antibodies, 2020–2028
Figure 261 : Chinese Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 262 : Chinese Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 263 : Chinese Market Shares of Research Antibodies, by Clonality, 2022
Figure 264 : Chinese Market Shares of Research Antibodies, by Clonality, 2028
Figure 265 : Chinese Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 266 : Chinese Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 267 : Chinese Market Shares of Research Antibodies, by Application, 2022
Figure 268 : Chinese Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 269 : Chinese Market Shares of Research Antibodies, by Application, 2028
Figure 270 : Chinese Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 271 : Chinese Market Shares of Research Antibodies, by Host Species, 2022
Figure 272 : Chinese Market Shares of Research Antibodies, by Host Species, 2028
Figure 273 : Chinese Market Shares of Research Antibodies, by End User, 2022
Figure 274 : Chinese Market Shares of Research Antibodies, by End User, 2028
Figure 275 : Chinese Market Growth Challenges, 2023
Figure 276 : Indian Market for Research Antibodies, 2020–2028
Figure 277 : Indian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 278 : Indian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 279 : Indian Market Shares of Research Antibodies, by Clonality, 2022
Figure 280 : Indian Market Shares of Research Antibodies, by Clonality, 2028
Figure 281 : Indian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 282 : Indian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 283 : Indian Market Shares of Research Antibodies, by Application, 2022
Figure 284 : Indian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 285 : Indian Market Shares of Research Antibodies, by Application, 2028
Figure 286 : Indian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 287 : Indian Market Shares of Research Antibodies, by Host Species, 2022
Figure 288 : Indian Market Shares of Research Antibodies, by Host Species, 2028
Figure 289 : Indian Market Shares of Research Antibodies, by End User, 2022
Figure 290 : Indian Market Shares of Research Antibodies, by End User, 2028
Figure 291 : Indian Market of Bioeconomy, 2021
Figure 292 : Indian Market of Bioeconomy’s Key Subsegment, 2021
Figure 293 : Australian and New Zealand Market for Research Antibodies, 2020–2028
Figure 294 : Australian and New Zealand Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 295 : Australian and New Zealand Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 296 : Australian and New Zealand Market Shares of Research Antibodies, by Clonality, 2022
Figure 297 : Australian and New Zealand Market Shares of Research Antibodies, by Clonality, 2028
Figure 298 : Australian and New Zealand Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 299 : Australian and New Zealand Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 300 : Australian and New Zealand Market Shares of Research Antibodies, by Application, 2022
Figure 301 : Australian and New Zealand Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 302 : Australian and New Zealand Market Shares of Research Antibodies, by Application, 2028
Figure 303 : Australian and New Zealand Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 304 : Australian and New Zealand Market Shares of Research Antibodies, by Host Species, 2022
Figure 305 : Australian and New Zealand Market Shares of Research Antibodies, by Host Species, 2028
Figure 306 : Australian and New Zealand Market Shares of Research Antibodies, by End User, 2022
Figure 307 : Australian and New Zealand Market Shares of Research Antibodies, by End User, 2028
Figure 308 : Australian and New Zealand Market Shares of Research Antibodies, by End User, 2028
Figure 309 : Rest of Asia-Pacific Market for Research Antibodies, 2020–2028
Figure 310 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 311 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 312 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2022
Figure 313 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2028
Figure 314 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 315 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 316 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Application, 2022
Figure 317 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 318 : Rest of Asia-Pacific Shares of Research Antibodies, by Application, 2028
Figure 319 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 320 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2022
Figure 321 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2028
Figure 322 : Rest of Asia-Pacific Market Shares of Research Antibodies, by End User, 2022
Figure 323 : Rest of Asia-Pacific Market Shares of Research Antibodies, by End User, 2028
Figure 324 : Rest of World Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 325 : Rest of World Market Shares of Research Antibodies, by Clonality, 2022
Figure 326 : Rest of World Market Shares of Research Antibodies Market, by Major Reactivity, 2022
Figure 327 : Rest of World Market Shares of Research Antibodies, by Application, 2022
Figure 328 : Rest of World Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 329 : Rest of World Market Shares of Research Antibodies, by Host Species, 2022
Figure 330 : Rest of World Market Shares of Research Antibodies, by End User, 2022
Figure 331 : Rest of the World Market Shares of Research Antibodies, by Country/Region, 2022
Figure 332 : Brazilian Market for Research Antibodies, 2020–2028
Figure 333 : Brazilian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 334 : Brazilian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 335 : Brazilian Market Shares of Research Antibodies, by Clonality, 2022
Figure 336 : Brazilian Market Shares of Research Antibodies, by Clonality, 2028
Figure 337 : Brazilian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 338 : Brazilian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 339 : Brazilian Market Shares of Research Antibodies, by Application, 2022
Figure 340 : Brazilian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 341 : Brazilian Market Shares of Research Antibodies, by Application, 2028
Figure 342 : Brazilian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 343 : Brazilian Market Shares of Research Antibodies, by Host Species, 2022
Figure 344 : Brazilian Market Shares of Research Antibodies, by Host Species, 2028
Figure 345 : Brazilian Market Shares of Research Antibodies, by End User, 2022
Figure 346 : Brazilian Market Shares of Research Antibodies, by End User, 2028
Figure 347 : GCC Countries Market for Research Antibodies, 2020–2028
Figure 348 : GCC countries Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 349 : GCC Countries Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 350 : GCC Countries Market Shares of Research Antibodies, by Clonality, 2022
Figure 351 : GCC Countries Market Shares of Research Antibodies, by Clonality, 2028
Figure 352 : GCC Countries Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 353 : GCC Countries Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 354 : GCC countries Market Shares of Research Antibodies, by Application, 2022
Figure 355 : GCC Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 356 : GCC Countries Market Shares of Research Antibodies, by Application, 2028
Figure 357 : GCC Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 358 : GCC Countries Market Shares of Research Antibodies, by Host Species, 2022
Figure 359 : GCC Countries Market Shares of Research Antibodies, by Host Species, 2028
Figure 360 : GCC Countries Market Shares of Research Antibodies, by End User, 2022
Figure 361 : GCC Countries Market Shares of Research Antibodies, by End User, 2028
Figure 362 : Rest of World Countries Market for Research Antibodies, 2020–2028
Figure 363 : Rest of World Countries Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 364 : Rest of World Countries Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 365 : Rest of World Countries Market Shares of Research Antibodies, by Clonality, 2022
Figure 366 : Rest of World Countries Market Shares of Research Antibodies, by Clonality, 2028
Figure 367 : Rest of World Countries Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 368 : Rest of World Countries Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 369 : Rest of World Countries Market Shares of Research Antibodies, by Application, 2022
Figure 370 : Rest of World Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 371 : Rest of World Countries Market Shares of Research Antibodies, by Application, 2028
Figure 372 : Rest of World Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 373 : Rest of World Countries Market Shares of Research Antibodies, by Host Species, 2022
Figure 374 : Rest of World Countries Market Shares of Research Antibodies, by Host Species, 2028
Figure 375 : Rest of World Countries Market Shares of Research Antibodies, by End User, 2022
Figure 376 : Rest of World Countries Market Shares of Research Antibodies, by End User, 2028
Figure 377 : U.S. versus the Rest of the World Market Shares of Monoclonal Antibodies, 2021
Figure 378 : Snapshot: Key Environmental, So